Please enable JavaScript to continue using this application.

Compare $SNDX vs $ZYME | Chartloom

Compare

$SNDX vs $ZYME

Syndax Pharmaceuticals Inc · Zymeworks Inc

SNDX

Syndax Pharmaceuticals Inc

ZYME

Zymeworks Inc

Compare $SNDX vs $ZYME

Comparing Syndax Pharmaceuticals Inc and Zymeworks Inc

SNDXSyndax Pharmaceuticals Inc

ZYMEZymeworks Inc

SNDXSyndax Pharmaceuticals Inc

Market cap

$1.51B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

222.7%

YTD performance

-20.2%

52W performance

3.0%

FCF yield

-14.7%

ZYMEZymeworks Inc

Market cap

$1.85B

P/E (TTM)

—

Forward P/E (NTM)

8.20x

Forward P/S (NTM)

3.91x

Rev growth (TTM)

-69.8%

YTD performance

-3.1%

52W performance

54.6%

FCF yield

-6.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

SNDX

ZYME

Detailed metrics comparison

SNDX

Syndax Pharmaceuticals Inc

ZYME

Zymeworks Inc

Market Cap

SNDX$1.51B

ZYME$1.85B

Enterprise Value

SNDX$1.76B

ZYME$1.92B

Price

SNDX$16.99

ZYME$25.79

P/E Ratio

SNDXN/A

ZYMEN/A

P/S Ratio

SNDX5.97x

ZYME49.73x

EV/Sales

SNDX6.97x

ZYME51.70x

EV/EBITDA

SNDX1,613.51x

ZYME9.18x

P/B Ratio

SNDX104.09x

ZYME23.27x

P/FCF Ratio

SNDXN/A

ZYMEN/A

EV/FCF

SNDX-7.96x

ZYME-15.91x

PEG Ratio

SNDXN/A

ZYMEN/A

Forward P/E (NTM)

SNDXN/A

ZYME8.20x

Forward P/S (NTM)

SNDXN/A

ZYME3.91x

Revenue (TTM)

SNDX$252M

ZYME$37M

Revenue Growth (YoY)

SNDX222.7%

ZYME-69.8%

Forward Rev Growth

SNDX41.0%

ZYME-15.2%

Gross Margin (TTM)

SNDX95.8%

ZYME0.0%

Operating Margin (TTM)

SNDX0.0%

ZYME0.0%

EBITDA Margin (TTM)

SNDX-77.0%

ZYME-405.8%

Net Margin (TTM)

SNDX-87.5%

ZYME-404.0%

FCF Margin (TTM)

SNDX-87.6%

ZYME-325.1%

Net Income (TTM)

SNDX$-221M

ZYME$-150M

FCF (TTM)

SNDX$-221M

ZYME$-121M

EPS (TTM)

SNDX-$2.48

ZYME-$2.05

ROE (TTM)

SNDX-37294.0%

ZYME-7207.0%

ROA (TTM)

SNDX-3911.0%

ZYME-3706.0%

ROIC (TTM)

SNDX-4756.0%

ZYME-4505.0%

Cash

SNDX$336M

ZYME$179M

Debt

SNDX$588M

ZYME$253M

Net Cash/Debt

SNDX$-252M

ZYME$-73M

Current Ratio (TTM)

SNDX6.77x

ZYME6.32x

Quick Ratio (TTM)

SNDX6.32x

ZYME5.86x

Debt/Equity (TTM)

SNDX38.95x

ZYME3.14x

Debt/Assets (TTM)

SNDX0.0%

ZYME0.0%

Interest Coverage (TTM)

SNDXN/A

ZYMEN/A

Net Debt/EBITDA (TTM)

SNDX0.00x

ZYME0.00x

Beta

SNDX0.40

ZYME1.32

52W Performance

SNDX3.0%

ZYME54.6%

YTD Performance

SNDX-20.2%

ZYME-3.1%

% from 52W High

SNDX-33.6%

ZYME-17.7%

% from 52W Low

SNDX30.8%

ZYME61.2%

Asset Turnover (TTM)

SNDX0.45x

ZYME0.09x

FCF Yield (TTM)

SNDX-14.7%

ZYME-6.5%

Earnings Yield (TTM)

SNDX-14.7%

ZYME-8.1%

Dividend Yield (TTM)

SNDXN/A

ZYMEN/A

Rule of 40

SNDX135.1

ZYME-394.8

EV/GP/RG

SNDX0.15

ZYMEN/A

Ticker research

View SNDX research View ZYME research

Metric	SNDX Syndax Pharmaceuticals Inc	ZYME Zymeworks Inc
Market & Valuation
Market Cap	$1.51B	$1.85B
Enterprise Value	$1.76B	$1.92B
Price	$16.99	$25.79
P/E Ratio	N/A	N/A
P/S Ratio	5.97x	49.73x
EV/Sales	6.97x	51.70x
EV/EBITDA	1,613.51x	9.18x
P/B Ratio	104.09x	23.27x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.96x	-15.91x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	8.20x
Forward P/S (NTM)	N/A	3.91x
Revenue & Growth
Revenue (TTM)	$252M	$37M
Revenue Growth (YoY)	222.7%	-69.8%
Forward Rev Growth	41.0%	-15.2%
Profitability
Gross Margin (TTM)	95.8%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-77.0%	-405.8%
Net Margin (TTM)	-87.5%	-404.0%
FCF Margin (TTM)	-87.6%	-325.1%
Net Income (TTM)	$-221M	$-150M
FCF (TTM)	$-221M	$-121M
EPS (TTM)	-$2.48	-$2.05
ROE (TTM)	-37294.0%	-7207.0%
ROA (TTM)	-3911.0%	-3706.0%
ROIC (TTM)	-4756.0%	-4505.0%
Financial Health
Cash	$336M	$179M
Debt	$588M	$253M
Net Cash/Debt	$-252M	$-73M
Current Ratio (TTM)	6.77x	6.32x
Quick Ratio (TTM)	6.32x	5.86x
Debt/Equity (TTM)	38.95x	3.14x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.40	1.32
52W Performance	3.0%	54.6%
YTD Performance	-20.2%	-3.1%
% from 52W High	-33.6%	-17.7%
% from 52W Low	30.8%	61.2%
Efficiency & Yields
Asset Turnover (TTM)	0.45x	0.09x
FCF Yield (TTM)	-14.7%	-6.5%
Earnings Yield (TTM)	-14.7%	-8.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	135.1	-394.8
EV/GP/RG	0.15	N/A
Ticker research	View SNDX research	View ZYME research

Valuation

P/S Ratio

SNDX

5.97x

ZYME

49.73x

EV/FCF

ZYME

-15.91x

SNDX

-7.96x

Growth & revenue

Revenue Growth TTM

SNDX

222.7%

ZYME

-69.8%

Forward Revenue Growth

SNDX

41.0%

ZYME

-15.2%

Profitability & performance

Gross Margin

SNDX

95.8%

ZYME

0.0%

ROE

ZYME

-7207.0%

SNDX

-37294.0%

FCF Yield %

ZYME

-6.5%

SNDX

-14.7%

52-Week Performance

ZYME

54.6%

SNDX

3.0%

Detailed metrics comparison

SNDX

Syndax Pharmaceuticals Inc

ZYME

Zymeworks Inc

Market Cap

SNDX$1.51B

ZYME$1.85B

Enterprise Value

SNDX$1.76B

ZYME$1.92B

Price

SNDX$16.99

ZYME$25.79

P/E Ratio

SNDXN/A

ZYMEN/A

P/S Ratio

SNDX5.97x

ZYME49.73x

EV/Sales

SNDX6.97x

ZYME51.70x

EV/EBITDA

SNDX1,613.51x

ZYME9.18x

P/B Ratio

SNDX104.09x

ZYME23.27x

P/FCF Ratio

SNDXN/A

ZYMEN/A

EV/FCF

SNDX-7.96x

ZYME-15.91x

PEG Ratio

SNDXN/A

ZYMEN/A

Forward P/E (NTM)

SNDXN/A

ZYME8.20x

Forward P/S (NTM)

SNDXN/A

ZYME3.91x

Revenue (TTM)

SNDX$252M

ZYME$37M

Revenue Growth (YoY)

SNDX222.7%

ZYME-69.8%

Forward Rev Growth

SNDX41.0%

ZYME-15.2%

Gross Margin (TTM)

SNDX95.8%

ZYME0.0%

Operating Margin (TTM)

SNDX0.0%

ZYME0.0%

EBITDA Margin (TTM)

SNDX-77.0%

ZYME-405.8%

Net Margin (TTM)

SNDX-87.5%

ZYME-404.0%

FCF Margin (TTM)

SNDX-87.6%

ZYME-325.1%

Net Income (TTM)

SNDX$-221M

ZYME$-150M

FCF (TTM)

SNDX$-221M

ZYME$-121M

EPS (TTM)

SNDX-$2.48

ZYME-$2.05

ROE (TTM)

SNDX-37294.0%

ZYME-7207.0%

ROA (TTM)

SNDX-3911.0%

ZYME-3706.0%

ROIC (TTM)

SNDX-4756.0%

ZYME-4505.0%

Cash

SNDX$336M

ZYME$179M

Debt

SNDX$588M

ZYME$253M

Net Cash/Debt

SNDX$-252M

ZYME$-73M

Current Ratio (TTM)

SNDX6.77x

ZYME6.32x

Quick Ratio (TTM)

SNDX6.32x

ZYME5.86x

Debt/Equity (TTM)

SNDX38.95x

ZYME3.14x

Debt/Assets (TTM)

SNDX0.0%

ZYME0.0%

Interest Coverage (TTM)

SNDXN/A

ZYMEN/A

Net Debt/EBITDA (TTM)

SNDX0.00x

ZYME0.00x

Beta

SNDX0.40

ZYME1.32

52W Performance

SNDX3.0%

ZYME54.6%

YTD Performance

SNDX-20.2%

ZYME-3.1%

% from 52W High

SNDX-33.6%

ZYME-17.7%

% from 52W Low

SNDX30.8%

ZYME61.2%

Asset Turnover (TTM)

SNDX0.45x

ZYME0.09x

FCF Yield (TTM)

SNDX-14.7%

ZYME-6.5%

Earnings Yield (TTM)

SNDX-14.7%

ZYME-8.1%

Dividend Yield (TTM)

SNDXN/A

ZYMEN/A

Rule of 40

SNDX135.1

ZYME-394.8

EV/GP/RG

SNDX0.15

ZYMEN/A

Ticker research

View SNDX research View ZYME research

Metric	SNDX Syndax Pharmaceuticals Inc	ZYME Zymeworks Inc
Market & Valuation
Market Cap	$1.51B	$1.85B
Enterprise Value	$1.76B	$1.92B
Price	$16.99	$25.79
P/E Ratio	N/A	N/A
P/S Ratio	5.97x	49.73x
EV/Sales	6.97x	51.70x
EV/EBITDA	1,613.51x	9.18x
P/B Ratio	104.09x	23.27x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.96x	-15.91x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	8.20x
Forward P/S (NTM)	N/A	3.91x
Revenue & Growth
Revenue (TTM)	$252M	$37M
Revenue Growth (YoY)	222.7%	-69.8%
Forward Rev Growth	41.0%	-15.2%
Profitability
Gross Margin (TTM)	95.8%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-77.0%	-405.8%
Net Margin (TTM)	-87.5%	-404.0%
FCF Margin (TTM)	-87.6%	-325.1%
Net Income (TTM)	$-221M	$-150M
FCF (TTM)	$-221M	$-121M
EPS (TTM)	-$2.48	-$2.05
ROE (TTM)	-37294.0%	-7207.0%
ROA (TTM)	-3911.0%	-3706.0%
ROIC (TTM)	-4756.0%	-4505.0%
Financial Health
Cash	$336M	$179M
Debt	$588M	$253M
Net Cash/Debt	$-252M	$-73M
Current Ratio (TTM)	6.77x	6.32x
Quick Ratio (TTM)	6.32x	5.86x
Debt/Equity (TTM)	38.95x	3.14x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.40	1.32
52W Performance	3.0%	54.6%
YTD Performance	-20.2%	-3.1%
% from 52W High	-33.6%	-17.7%
% from 52W Low	30.8%	61.2%
Efficiency & Yields
Asset Turnover (TTM)	0.45x	0.09x
FCF Yield (TTM)	-14.7%	-6.5%
Earnings Yield (TTM)	-14.7%	-8.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	135.1	-394.8
EV/GP/RG	0.15	N/A
Ticker research	View SNDX research	View ZYME research